By leveraging artificial intelligence combined with licensed medical professionals, Doctronic.ai helps bridge the gap between patients and healthcare providers
doi: 10.1038/s41577-022-00762-9 72 PetersenMARyuJKAkassoglouK
Whether you're in a Center City high-rise or a suburban home in Lancaster, we bring this powerful therapy directly to you
Heres whats coming soon, and whats in clinical trials: Orforglipron (brand name Foundayo): A once-daily oral GLP-1 was just approved by the FDA for weight loss, and will hopefully be approved for type 2 diabetes soon
In the liver, it decreases glucose production, while in the pancreas it promotes insulin release and beta-cell proliferation
Preparing for injection: Before administering your GLP-1 medication, allow the pen to reach room temperature if it has been refrigeratedthis reduces injection discomfort